South African virus variant may resist antibody drugs; Pfizer/BioNTech vaccine seems to work vs UK variant


  • World
  • Thursday, 21 Jan 2021

FILE PHOTO: A vial and sryinge are seen in front of a displayed Pfizer and Biontech logo in this illustration taken January 11, 2021. REUTERS/Dado Ruvic

(Reuters) - The following is a roundup of some of the latest scientific studies on the novel coronavirus and efforts to find treatments and vaccines for COVID-19, the illness caused by the virus.

South African variant may resist current antibody treatments

Limited time offer:
Just RM5 per month.

Monthly Plan

RM13.90/month
RM5/month

Billed as RM5/month for the 1st 6 months then RM13.90 thereafters.

Annual Plan

RM12.33/month

Billed as RM148.00/year

1 month

Free Trial

For new subscribers only


Cancel anytime. No ads. Auto-renewal. Unlimited access to the web and app. Personalised features. Members rewards.
Follow us on our official WhatsApp channel for breaking news alerts and key updates!
   

Next In World

Italy passes contested plan to 'support motherhood' in abortion clinics
Feature: Concert marks Chinese Language Day in Geneva
1st LD: Chinese business group "shocked, dissatisfied" over EU raids on Chinese company
Young Germans unhappy with politics, socio-economic developments: survey
Urgent: Chinese business group "shocked, dissatisfied" over EU raids on Chinese company
Ghanaian industry leader urges packaging improvement to leverage AfCFTA opportunities
South Africa's Cape Town to become Africa's wealthiest city by 2030: report
Growing public debt burden, shrinking fiscal space leave Africa at crossroads: UNECA
Africa's Travel Indaba 2024 to be held in South Africa's Durban
Ministers root for upgrading vocational training to spur industrial growth in Africa

Others Also Read